1
|
Fayiga FF, Reyes-Hadsall SC, Moreno BA, Oh KS, Brathwaite C, Duarte AM. Novel ANKRD26 and PDGFRB gene mutations in pediatric case of non-Langerhans cell histiocytosis: Case report and literature review. J Cutan Pathol 2023; 50:425-429. [PMID: 36753059 DOI: 10.1111/cup.14404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Revised: 01/30/2023] [Accepted: 02/06/2023] [Indexed: 02/09/2023]
Abstract
Cutaneous non-Langerhans cell histiocytosis (NLCH) is a rare and biologically benign entity that can be broadly classified into two categories: xanthogranuloma and non-xanthogranuloma. The xanthogranuloma family is characterized by a proliferation of histiocytes with both macrophage and dendritic cell differentiation, negative BRAF mutation, and rare Touton-type giant cells. Molecular studies have reported that mutations involved in the MAPK signaling pathways are implicated in the pathophysiology of histiocytoses. While LCH is associated with the somatic mutation of BRAF v600e, however, mutations and gene fusions in NLCH cases are undefined. We hereby present a 19-month-old female with recalcitrant nodular rashes diagnosed as NLCH with associated novel genetic mutation involving ANKRD26 and PDGFRB genes, as well as PDGFRB::CD74 fusion mRNA. Immunohistochemical staining showed strong and diffuse CD68 and CD163 positivity, and negative CD1a, CD207, ALK D5F3, S100 protein, and BRAF V600E (VE1). Albeit unknown significance, this case of an ANKRD26 and PDGFRB gene mutation in cutaneous NLCH has not been reported prior in the literature. Our case highlights the advantage of pathology and genetic studies in cutaneous NLCH to increase the understanding of this heterogeneous enigmatic disorder and identify further options in management.
Collapse
Affiliation(s)
- Folasade F Fayiga
- Children's Skin Center, Miami, Florida, USA.,Division of Dermatology, Department of Pediatrics, Nicklaus Children's Hospital, Miami, Florida, USA.,Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA
| | - Sophia C Reyes-Hadsall
- Children's Skin Center, Miami, Florida, USA.,Division of Dermatology, Department of Pediatrics, Nicklaus Children's Hospital, Miami, Florida, USA.,University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Brian A Moreno
- Children's Skin Center, Miami, Florida, USA.,Division of Dermatology, Department of Pediatrics, Nicklaus Children's Hospital, Miami, Florida, USA.,Lake Erie College of Osteopathic Medicine, Bradenton, Florida, USA
| | - Kei Shing Oh
- Mount Sinai Medical Center, Miami Beach, Florida, USA
| | - Carole Brathwaite
- Department of Pathology and Laboratory Medicine, Nicklaus Children's Hospital, Miami, Florida, USA
| | - Ana M Duarte
- Children's Skin Center, Miami, Florida, USA.,Division of Dermatology, Department of Pediatrics, Nicklaus Children's Hospital, Miami, Florida, USA
| |
Collapse
|
2
|
Goto K, Yoshikawa S, Kiyohara Y, Kukita Y, Miura K, Oishi T. Co-existence of BRAF V600E-mutated malignant melanoma and BRAF V600E-mutated Langerhans cell histiocytosis: A case report. J Cutan Pathol 2021; 49:393-398. [PMID: 34792818 DOI: 10.1111/cup.14171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Revised: 11/05/2021] [Accepted: 11/14/2021] [Indexed: 11/26/2022]
Abstract
Langerhans cell histiocytosis (LCH) is a neoplastic condition of Langerhans cells, and can be associated with other neoplasms, especially BRAF-mutant hematological tumors and papillary thyroid carcinoma. Here we present the first case of co-existing LCH and low cumulative sun damage (low-CSD) melanoma, both of which had a BRAF V600E mutation. A 49-year-old man had a 45 × 43 × 15 mm semi-pedunculated, pigmented tumor in his back but had no other systemic symptoms. Histopathology revealed a 2-mm-sized incidental focus of LCH within a large lesion of low-CSD melanoma. Diffuse immunoexpression of CD1a, langerin/CD207, S100 protein, and BRAF (VE1) was observed in the focus of LCH. Sanger sequencing with microdissection confirmed BRAF V600E mutation in the component of LCH. Interestingly, the advanced melanoma also harbored the same BRAF V600E mutation, although the significance of this tumor combination is still unknown.
Collapse
Affiliation(s)
- Keisuke Goto
- Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan.,Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.,Department of Pathology, Itabashi Central Clinical Laboratory, Tokyo, Japan.,Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.,Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.,Department of Diagnostic Pathology, Osaka National Hospital, Osaka, Japan.,Department of Dermatology, Hyogo Cancer Center, Akashi, Japan
| | - Shusuke Yoshikawa
- Department of Dermatology, Shizuoka Cancer Center Hospital, Sunto, Japan
| | - Yoshio Kiyohara
- Department of Dermatology, Shizuoka Cancer Center Hospital, Sunto, Japan
| | - Yoji Kukita
- Laboratory of Genomic Pathology, Research Center, Osaka International Cancer Institute, Osaka, Japan
| | - Keiko Miura
- Department of Surgical Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
| | - Takuma Oishi
- Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan
| |
Collapse
|
3
|
Di Stefano G, Granai M, Giudici F, Roselli G, Lazzi S, Santi R. Xanthomatous Inflammatory Infiltrate Involving the Spleen: An Unusual Presentation of Erdheim-Chester Disease and Review of the Literature. AMERICAN JOURNAL OF CASE REPORTS 2021; 22:e931060. [PMID: 34083501 PMCID: PMC8183300 DOI: 10.12659/ajcr.931060] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Patient: Male, 63-year-old Final Diagnosis: Erdheim-Chester disease Symptoms: Splenic rupture Medication: — Clinical Procedure: Splenectomy Specialty: Anatomy • Hematology • Pathology
Collapse
Affiliation(s)
- Gioia Di Stefano
- Pathology Section, Department of Medical Biotechnology, University of Siena, Siena, Italy.,Pathological Anatomy Section, Careggi University Hospital, Florence, Italy
| | - Massimo Granai
- Institute of Pathology, University Hospital of Tübingen, Tübingen, Germany
| | - Francesco Giudici
- Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy
| | - Giuliana Roselli
- Department of Diagnostic Imaging, Careggi University Hospital, Florence, Italy
| | - Stefano Lazzi
- Pathology Section, Department of Medical Biotechnology, University of Siena, Siena, Italy
| | - Raffaella Santi
- Pathological Anatomy Section, Careggi University Hospital, Florence, Italy
| |
Collapse
|